×
About 140 results

ALLMedicine™ Nontuberculous Mycobacterial Lung Disease Center

Research & Reviews  48 results

Drug development challenges in nontuberculous mycobacterial lung disease: TB to the res...
https://doi.org/10.1084/jem.20220445
The Journal of Experimental Medicine; Dartois V, Dick T

May 12th, 2022 - Nontuberculous mycobacterial pulmonary disease (NTM-PD) is treated with multiple repurposed drugs. Chemotherapy is long and often toxic, includes parenteral drugs, and suffers from poor cure rates. There is an urgent need for more efficacious, tol...

A Rabbit Model to Study Antibiotic Penetration at the Site of Infection for Nontubercul...
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8923217
Antimicrobial Agents and Chemotherapy; Kaya F, Ernest JP et. al.

Feb 1st, 2022 - Nontuberculous mycobacterial pulmonary disease (NTM-PD) is a potentially fatal infectious disease requiring long treatment duration with multiple antibiotics and against which there is no reliable cure. Among the factors that have hampered the dev...

Sputum Proteomics in Nontuberculous Mycobacterial Lung Disease.
https://doi.org/10.1016/j.chest.2021.11.014
Chest Hull RC, Huang JTJ et. al.

Nov 29th, 2021 - Nontuberculous mycobacterial (NTM) infections are difficult to diagnose and treat. Biomarkers to identify patients with active infection or at risk of disease progression would have clinical utility. Sputum is the most frequently used matrix for t...

Disease progression in patients with nontuberculous mycobacterial lung disease of nodul...
https://doi.org/10.1093/cid/ciab929
Clinical Infectious Diseases : an Official Publication Of... Pan SW, Su WJ et. al.

Nov 3rd, 2021 - In patients with nodular bronchiectatic (NB) nontuberculous mycobacterial-lung disease (NTM-LD), risk factors for disease progression have not been clearly investigated. The roles of cavitary NB and soluble programmed death protein-1 (sPD-1), an i...

Nontuberculous mycobacterial lung disease caused by Mycobacterium avium complex - disea...
https://doi.org/10.1080/17476348.2021.1987891
Expert Review of Respiratory Medicine; van Ingen J, Obradovic M et. al.

Oct 7th, 2021 - Nontuberculous mycobacterial (NTM) lung disease (LD) is the most common clinical manifestation of NTM infection and is a growing health concern. Up to 85% of NTM-LD cases are caused by Mycobacterium avium complex (MAC). Increased awareness of NTM-...

see more →

Guidelines  1 results

2021 American College of Rheumatology Guideline for the Treatment of Rheumatoid Arthritis.
https://doi.org/10.1002/art.41752
Arthritis & Rheumatology (Hoboken, N.J.); Fraenkel L, Bathon JM et. al.

Jun 9th, 2021 - To develop updated guidelines for the pharmacologic management of rheumatoid arthritis. We developed clinically relevant population, intervention, comparator, and outcomes (PICO) questions. After conducting a systematic literature review, the Grad...

see more →

Clinicaltrials.gov  1 results

Study of Nontuberculous Mycobacterial Lung Disease
https://clinicaltrials.gov/ct2/show/NCT00970801

Nov 25th, 2020 - The incidence of pulmonary disease caused by nontuberculous mycobacteria (NTM) has been increasing, and a substantial proportion of these patients have no preexisting lung disease and no demonstrable immunodeficiency. These patients are predominan...

see more →

News  6 results

Nontuberculous Mycobacterial Lung Disease Can Be Challenging to Treat
https://www.medscape.com/viewarticle/971985

Apr 12th, 2022 - Living in coastal areas of Florida and California has great appeal for many, with the warm, sunny climate and nearby freshwater and saltwater. But, unknown to many, those balmy coasts also carry the risk of infection from nontuberculous (atypical)...

Nontuberculous mycobacterial lung disease cases on the rise across U.S.
https://www.mdedge.com/fedprac/article/215787/infectious-diseases/nontuberculous-mycobacterial-lung-disease-cases-rise?channel=234
Steve Cimino

Jan 21st, 2020 - A new study of claims-based data has found that the incidence and prevalence of nontuberculous mycobacterial (NTM) lung disease is increasing in most states. Dr.

Nontuberculous mycobacterial lung disease cases on the rise across U.S.
https://www.mdedge.com/chestphysician/article/215787/infectious-diseases/nontuberculous-mycobacterial-lung-disease-cases
Steve Cimino, MDedge News

Jan 21st, 2020 - A new study of claims-based data has found that the incidence and prevalence of nontuberculous mycobacterial (NTM) lung disease is increasing in most states. Dr.

FDA Clears Antibacterial Arikayce for MAC Lung Disease
https://www.staging.medscape.com/viewarticle/902764

Oct 1st, 2018 - The US Food and Drug Administration (FDA) has approved amikacin liposome inhalation suspension (Arikayce, Insmed) for the treatment of Mycobacterium avium complex (MAC) lung disease in adults with limited or no alternative treatment options. Arika...

FDA Clears Antibacterial Arikayce for MAC Lung Disease
https://www.medscape.com/viewarticle/902764

Oct 1st, 2018 - The US Food and Drug Administration (FDA) has approved amikacin liposome inhalation suspension (Arikayce, Insmed) for the treatment of Mycobacterium avium complex (MAC) lung disease in adults with limited or no alternative treatment options. Arika...

see more →